# Dose Range Study to Evaluate the Efficacy and Safety of AV5080 in Patients With Influenza

> **NCT05095545** · PHASE2 · COMPLETED · sponsor: **Viriom** · enrollment: 135 (actual)

## Conditions studied

- Influenza

## Interventions

- **DRUG:** AV5080
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT05095545
- **Lead sponsor:** Viriom
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-11-13
- **Primary completion:** 2019-08-07
- **Final completion:** 2019-08-30
- **Target enrollment:** 135 (ACTUAL)
- **Last updated:** 2021-10-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05095545

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05095545, "Dose Range Study to Evaluate the Efficacy and Safety of AV5080 in Patients With Influenza". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05095545. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*